Mahzi Therapeutics is a biotech company focused on treating under-served rare genetic neurodevelopmental disorders. We are so honored to be one of the first 3 indications in Mahzi’z introductory pipeline. Mahzi is taking the gene therapy work started by the Muotri Lab at UCSD and completing the preclinical and regulatory steps to bring the work to trial.